516
Participants
Start Date
January 5, 2010
Primary Completion Date
June 9, 2011
Study Completion Date
July 27, 2012
Mavrilimumab 10 mg
Mavrilimumab (CAM-3001) 10 mg injection subcutaneously every other week for 12 weeks.
Mavrilimumab 30 mg
Mavrilimumab (CAM-3001) 30 mg injection subcutaneously every other week for 12 weeks.
Mavrilimumab 50 mg
Mavrilimumab (CAM-3001) 50 mg injection subcutaneously every other week for 12 weeks.
Mavrilimumab 100 mg
Mavrilimumab (CAM-3001) 100 mg injection subcutaneously every other week for 12 weeks.
Placebo
Placebo matched to mavrilimumab injection subcutaneously every other week for 12 weeks.
Research Site, Plovdiv
Research Site, Sofia
Research Site, Varna
Research Site, Bruntál
Research Site, Ostrava - Trebovice
Research Site, Prague
Research Site, Praha 4 - Nusle
Research Site, Uherské Hradiště
Research Site, Zlín
Research Site, Tallinn
Research Site, Budapest
Research Site, Sopron
Research Site, Zalaegerszeg
Research Site, Chiba
Research Site, Chiyoda-ku
Research Site, Fukui-shi
Research Site, Fukuoka
Research Site, Goshogawara-shi
Research Site, Hamamatsu
Research Site, Iizuka-shi
Research Site, Kagoshima
Research Site, Kasama-shi
Research Site, Kitakyushu-shi
Research Site, Nagano
Research Site, Nagoya
Research Site, Okayama
Research Site, Omura-shi
Research Site, Sagamihara-shi
Research Site, Sasebo-shi
Research Site, Shinjuku-ku
Research Site, Liepāja
Research Site, Riga
Research Site, Valmiera
Research Site, Klaipėda
Research Site, Vilnius
Research Site, Bialystok
Research Site, Bydgoszcz
Research Site, Katowice
Research Site, Legnica
Research Site, Lublin
Research Site, Poznan
Research Site, Torun
Research Site, Warsaw
Research Site, Bucharest
Research Site, Ploieşti
Research Site, Târgu Mureş
Research Site, Barnaul
Research Site, Kazan'
Research Site, Kemerovo
Research Site, Novosibirsk
Research Site, Saint Petersburg
Research Site, Yaroslavl
Research Site, Donetsk
Research Site, Kiev
Research Site, Kyiv
Lead Sponsor
Collaborators (1)
MedImmune Ltd
INDUSTRY
MedImmune LLC
INDUSTRY